HGF Office

Munich

Neumarkter Str. 18,
81673 Munich,
Germany

View on Google Maps

Contact the office

HGF is dedicated to providing a comprehensive service both across Germany and internationally. Contact us to find out how we can work with your business.

Tel. +49 (0)89 1259 9600

Email our team

HGF Munich opened in 2019 following the merger of HGF and Patronus IP.

Munich is the centre of industrial property rights in Europe, playing host to the seat of the German Patent and Trade Mark Office, the European Patent Office with its Boards of Appeal, and a large part of its Examining and Oppositions Divisions. The central office location allows the team to reach out quickly to the nearby offices and courts to represent our clients’ interests.

Our professional team’s collective experience and expertise allows us to provide our clients with a winning combination of technical and commercially sound advice.

Our team: Munich

Search for a specialist

    Use the options below to select one or more search areas

    UPC Representative

    Gary
    Wilson

    Partner & Patent Attorney
    UPC Representative

    Bernhard
    Ganahl

    Partner & Patent Attorney

    Julia
    Saladin

    Attorney-at-Law

    Christian
    Himmler

    Patent Director

    Rudolf
    Erhardt Sachs

    Senior European Patent Attorney

    Olivia
    Petter

    Attorney-at-Law
    UPC Representative

    Dominique
    Trösch

    Consultant

    Lena
    Krinner

    Trainee Patent Attorney

    Alexander
    Mann

    Trainee Patent Attorney

    Claudia-Maria
    Jafari

    Patent Formalities Officer

    Fabian
    Hardt

    Patent Formalities Manager

    Madalina
    Elena Dumitru-Hentea

    Patent Formalities Officer
    Load More

    Latest updates

    The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

    The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

    Read article

    Regulatory Exclusivity for
Medicinal Products in Europe

    Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

    Read article

    Added Matter - Part 2

    Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

    Read article

    Added Matter - Part 1

    Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

    Read article

    Patenting Polymorphs at the EPO

    Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

    Read article

    Antibodies

    Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

    Read article

    Description Amendment Requirements at EPO

    Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

    Read article
    See all updates